Literature DB >> 1576142

Heart transplantation for end-stage cardiomyopathy caused by an occult pheochromocytoma.

C Wilkenfeld1, M Cohen, S L Lansman, M Courtney, M R Dische, D Pertsemlidis, L R Krakoff.   

Abstract

Dilated cardiomyopathy has been found in patients with pheochromocytoma. The cardiomyopathy and resultant congestive heart failure can be progressive and fatal, or reversible, if the source of the excess catecholamines is removed. Histologic and autopsy studies revealed a characteristic focal myocarditis and contraction band necrosis, indicating that the circulating catecholamine excess secreted by the pheochromocytoma is the cause of the cardiomyopathy.

Entities:  

Mesh：

Year:  1992        PMID： 1576142

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


  12 in total

Review 1.  Pheochromocytoma as an endocrine emergency.

Authors:  Frederieke M Brouwers; Jacques W M Lenders; Graeme Eisenhofer; Karel Pacak
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

Review 2.  Stress cardiomyopathy: aetiology and management.

Authors:  Radhakrishnan Ramaraj
Journal:  Postgrad Med J       Date:  2007-08       Impact factor: 2.401

3.  Pheochromocytoma presenting as acute decompensated heart failure reversed with medical therapy.

Authors:  Christopher M Mulla; Paul Ellis Marik
Journal:  BMJ Case Rep       Date:  2012-07-19

4.  Phaeochromocytoma presenting acutely as severe cardiac failure.

Authors:  D L Connolly; D A Mariathas
Journal:  J Accid Emerg Med       Date:  1994-06

5.  High blood pressure, ventricular tachycardia and transient left ventricular dysfunction: do not forget pheocromocytoma.

Authors:  Mario Gregori; Francesco Paneni; Michela D'Agostino; Giuliano Tocci; Andrea Ferrucci; Carmine Savoia
Journal:  High Blood Press Cardiovasc Prev       Date:  2011-06-01

Review 6.  Stress cardiomyopathy mimicking acute coronary syndrome: case presentation and review of the literature.

Authors:  H Grawe; M Katoh; H P Kühl
Journal:  Clin Res Cardiol       Date:  2006-01-12       Impact factor: 5.460

7.  [The use of magnesium sulfate during surgery of pheochromocytoma: apropos of 2 cases].

Authors:  P Drolet; M Girard
Journal:  Can J Anaesth       Date:  1993-06       Impact factor: 5.063

8.  Encapsulated pheochromocytoma cells secrete potent noncatecholamine factors.

Authors:  Hector R Mobine; George C Engelmayr; Nelson Moussazadeh; Tayyba R Anwar; Lisa E Freed; Elazer R Edelman
Journal:  Tissue Eng Part A       Date:  2009-07       Impact factor: 3.845

9.  Pheochromocytoma-induced cardiomyopathy is modulated by the synergistic effects of cell-secreted factors.

Authors:  Hector R Mobine; Aaron B Baker; Libin Wang; Hiroko Wakimoto; Kurt C Jacobsen; Christine E Seidman; J G Seidman; Elazer R Edelman
Journal:  Circ Heart Fail       Date:  2009-02-10       Impact factor: 8.790

Review 10.  Cardiac Dysfunction After Neurologic Injury: What Do We Know and Where Are We Going?

Authors:  Vijay Krishnamoorthy; G Burkhard Mackensen; Edward F Gibbons; Monica S Vavilala
Journal:  Chest       Date:  2015-12-28       Impact factor: 9.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.